SEGMENTS (Tables)

6 Months Ended

Jun. 30, 2024

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the six months ended June 30, 2024 and 2023:

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Six Months Ended on June 30, 2024
Revenue	$	6,458,005		$	-		$	-		$	755,248		$	7,213,253
Cost of Sales		(5,181,322	)		-			(3,387	)		(303,616	)		(5,488,325	)
Gross Profit (Loss)		1,276,683			-			(3,387	)		451,632			1,724,928
Operating Expenses		(939,866	)		(290,635	)		(1,115,063	)		(4,455,348	)		(6,800,912	)
Operating Income (Loss)		336,817			(290,635	)		(1,118,450	)		(4,003,716	)		(5,075,984	)
Other Income (Expense)		422,319			(1,850,609	)		(99,845	)		(1,859,637	)		(3,387,772	)
Net Income (Loss) Before Income Tax		759,136			(2,141,244	)		(1,218,295	)		(5,863,353	)		(8,463,756	)

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Six Months Ended on June 30, 2023
Revenue	$	19,515,728		$	28,074		$	12,786		$	524,196		$	20,080,784
Cost of Sales		(12,168,470	)		(9,139	)		(109,657	)		(140,508	)		(12,427,774	)
Gross Profit (Loss)		7,347,258			18,935			(96,871	)		383,688			7,653,010
Operating Expenses		(992,201	)		(202,430	)		(477,917	)		(2,960,696	)	$	(4,633,244	)
Operating Income (Loss)		6,355,057			(183,495	)		(574,788	)		(2,577,008	)		3,019,766
Other Income (Expense)		215,306			(1,091,514	)		835,888			(13,116,034	)	$	(13,156,354	)
Net Income (Loss) Before Income Tax		6,570,363			(1,275,009	)		261,100			(15,693,042	)		(10,136,588	)
June 30, 2024
Cash and Restricted Cash	$	4,024,232		$	198,995		$	450,636		$	15,089,517		$	19,763,380
Total Assets		52,381,204			3,690,191			2,839,056			34,550,370			93,460,821
December 31, 2023
Cash and Restricted Cash	$	3,323,210		$	430,807		$	568,702		$	23,566,574		$	27,889,293
Total Assets		62,989,233			5,845,269			2,450,876			55,028,650		$	126,314,028